Absorption
C max is about 23 mU/L. T max is about 1 h.

Distribution
0% to 9% bound to plasma proteins.

Elimination
Cl is 1.22 L/h/kg. The half-life is 81 min.

Peak
1 to 3 h.

Duration
3 to 5 h.

Special Populations
Children
Pharmacokinetics in children and adolescents with type 1 diabetes are similar to those of healthy adults and adults with type 1 diabetes.

Obesity Insulin aspart
Cl is reduced 28% in patients with a body mass index (BMI) more than 32 kg/m 2 compared with patients with a BMI less than 23 kg/m 2 .

1.低血糖：是在胰島素治療時最常出現的不愉快作用，低血糖症狀通常會突然發生。

2.一般性的副作用：開始使用胰島素時，可能會發生水腫及視力不正常。這些症狀通常是過渡性質的。

Alcohol, beta-blockers, clonidine, lithium salts
May potentiate or weaken the blood glucose–lowering effects of insulin.

ACE inhibitors, disopyramide, fenfluramine, fibrates, fluoxetine, MAOIs, octreotide, oral hypoglycemic agents, pentoxifylline, propoxyphene, salicylates, sulfa
antibiotics
May increase hypoglycemic effects of insulin.

Atypical antipsychotics, corticosteroids, danazol, diazoxide, diuretics, estrogens, glucagon, isoniazid, niacin, oral contraceptives, phenothiazines, protease inhibitors, somatropin, sympathomimetics, thyroid hormone
May decrease hypoglycemic effects of insulin.

Beta-blockers, clonidine, guanethidine, reserpine
Signs of hypoglycemia may be reduced or absent.

Pentamidine
May cause hypoglycemia, which may be followed by hyperglycemia.

藥品應置於攝氏 2 ~ 8 度冰箱內(勿冷凍)；如發生變質或過期，不可再使用。

已開封使用之藥品，於室溫25℃以下，陰涼乾燥處存放，可使用一個月。超過期限，未用完之藥品，應予丟棄。